JP2024520234A5 - - Google Patents
Info
- Publication number
- JP2024520234A5 JP2024520234A5 JP2023569757A JP2023569757A JP2024520234A5 JP 2024520234 A5 JP2024520234 A5 JP 2024520234A5 JP 2023569757 A JP2023569757 A JP 2023569757A JP 2023569757 A JP2023569757 A JP 2023569757A JP 2024520234 A5 JP2024520234 A5 JP 2024520234A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- psd
- group
- seq
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21173587 | 2021-05-12 | ||
| EP21173587.3 | 2021-05-12 | ||
| PCT/EP2022/062893 WO2022238530A1 (en) | 2021-05-12 | 2022-05-12 | Psd-95 inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520234A JP2024520234A (ja) | 2024-05-23 |
| JP2024520234A5 true JP2024520234A5 (https=) | 2025-05-19 |
Family
ID=75914418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023569757A Pending JP2024520234A (ja) | 2021-05-12 | 2022-05-12 | Ｐｓｄ－９５阻害剤及びその使用 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20240245793A1 (https=) |
| EP (1) | EP4337673B1 (https=) |
| JP (1) | JP2024520234A (https=) |
| KR (1) | KR20240007140A (https=) |
| CN (1) | CN117295755A (https=) |
| AU (1) | AU2022274309A1 (https=) |
| BR (1) | BR112023021410A2 (https=) |
| CA (1) | CA3218073A1 (https=) |
| ES (1) | ES3040762T3 (https=) |
| IL (1) | IL307244A (https=) |
| MX (1) | MX2023013313A (https=) |
| PL (1) | PL4337673T3 (https=) |
| SA (1) | SA523451347B1 (https=) |
| TW (1) | TW202306965A (https=) |
| WO (1) | WO2022238530A1 (https=) |
| ZA (1) | ZA202308712B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4706670A1 (en) * | 2023-04-26 | 2026-03-11 | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Psd-95 domain inhibitor, and preparation method therefor and use thereof |
| JP7723457B2 (ja) * | 2023-07-03 | 2025-08-14 | メスキュージェナシス株式会社 | 細胞膜透過性を有するペプチドおよびそのスクリーニング方法 |
| CN117164725B (zh) * | 2023-09-07 | 2024-05-10 | 湖南中晟全肽生物科技股份有限公司 | 一种突触后密度蛋白-95抑制剂多肽 |
| CN119569824A (zh) * | 2023-09-07 | 2025-03-07 | 湖南中晟全肽生物科技股份有限公司 | 作为神经保护剂的药用化合物及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010004003A2 (en) | 2008-07-09 | 2010-01-14 | University Of Copenhagen | Modified peptides as potent inhibitors of the psd-95/nmda receptor interaction |
| ES2544573T3 (es) | 2011-05-13 | 2015-09-01 | Københavns Universitet (University Of Copenhagen) | Inhibidores diméricos de afinidad elevada de PSD-95 y su uso para el tratamiento del daño cerebral isquémico y del dolor |
| WO2020083905A1 (en) * | 2018-10-22 | 2020-04-30 | University Of Copenhagen | Inhibitors of pick1 and uses thereof |
-
2022
- 2022-05-11 TW TW111117679A patent/TW202306965A/zh unknown
- 2022-05-12 KR KR1020237037930A patent/KR20240007140A/ko active Pending
- 2022-05-12 CN CN202280033562.9A patent/CN117295755A/zh active Pending
- 2022-05-12 IL IL307244A patent/IL307244A/en unknown
- 2022-05-12 CA CA3218073A patent/CA3218073A1/en active Pending
- 2022-05-12 BR BR112023021410A patent/BR112023021410A2/pt unknown
- 2022-05-12 PL PL22728608.5T patent/PL4337673T3/pl unknown
- 2022-05-12 WO PCT/EP2022/062893 patent/WO2022238530A1/en not_active Ceased
- 2022-05-12 AU AU2022274309A patent/AU2022274309A1/en not_active Abandoned
- 2022-05-12 ES ES22728608T patent/ES3040762T3/es active Active
- 2022-05-12 MX MX2023013313A patent/MX2023013313A/es unknown
- 2022-05-12 EP EP22728608.5A patent/EP4337673B1/en active Active
- 2022-05-12 JP JP2023569757A patent/JP2024520234A/ja active Pending
- 2022-05-12 US US18/559,157 patent/US20240245793A1/en active Pending
-
2023
- 2023-09-12 ZA ZA2023/08712A patent/ZA202308712B/en unknown
- 2023-10-30 SA SA523451347A patent/SA523451347B1/ar unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024520234A5 (https=) | ||
| JP7627726B2 (ja) | 細胞透過性ペプチド、それを含んだコンジュゲート、及びそれを含んだ組成物 | |
| VAN DE VEN et al. | NMR studies of lantibiotics: the structure of nisin in aqueous solution | |
| Pazgier et al. | Human defensins: synthesis and structural properties | |
| Appelt | Crystal structures of HIV-1 protease-inhibitor complexes | |
| KR101730680B1 (ko) | 치료용 펩티드 | |
| CN103732238A (zh) | 用于免疫调节的治疗性化合物 | |
| WO1997046547A1 (en) | β-SHEET NUCLEATING PEPTIDOMIMETICS | |
| De Visser et al. | Solid‐phase synthesis of polymyxin B1 and analogues via a safety‐catch approach | |
| Tamamura et al. | Structure-activity relationships of an anti-HIV peptide, T22 | |
| JP2002515403A (ja) | インドリシジン類似体およびその使用方法 | |
| JPWO1992004374A1 (ja) | 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤 | |
| JP4782782B2 (ja) | オリゴマーペプチドおよびｈｉｖ感染症の治療のためのその使用 | |
| WO2025251773A1 (zh) | 具有广谱抗菌活性的抗菌肽及其制备方法 | |
| JP3312946B2 (ja) | ウイルス感染・増殖抑制剤 | |
| JPH03275699A (ja) | 新規なペプチド | |
| JPS59170051A (ja) | 薬理活性を有するトリペプチド誘導体 | |
| KR102521182B1 (ko) | 결핵균 독소-항독소 시스템을 표적으로 하는 항균 스테이플 펩타이드 및 이의 용도 | |
| WO2009155789A1 (zh) | 抑制hiv感染的多肽及其衍生物 | |
| JP3296434B2 (ja) | 保護されたアミノ酸構成単位、生産と使用 | |
| JP2003505469A (ja) | β鎖会合を防止するためのＮ−置換Ｌ−アミノ酸を含むペプチド | |
| Higgins et al. | Comparison of the solution conformations of a human immunodeficiency virus peptidomimetic and its retro‐inverso isomer using H NMR spectroscopy | |
| Tsutsumi et al. | Rate enhancement and enantioselectivity in ester hydrolysis catalysed by cyclodextrin–peptide hybrids | |
| JP2005514385A (ja) | プリオン阻害ペプチド及びその誘導体 | |
| WO2006025536A1 (ja) | 抗sarsウイルス剤 |